Abera Bioscience
6.30 SEK
+0.80 %
Less than 1K followers
ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+0.80 %
-3.82 %
-7.35 %
-4.55 %
-19.75 %
+6.78 %
+35.19 %
-47.50 %
-42.99 %
Abera Bioscience operates in biotechnology. The company specializes in the development of vaccines based on a proprietary and patented platform. The technology is mainly used in the development of new vaccines, with a focus on the main areas of pneumococci and immuno-oncology. The operations are located throughout the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Read moreMarket cap
129.14M SEK
Turnover
5.45K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/5
2026
Interim report Q1'26
10/6
2026
General meeting '26
20/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Abera Bioscience: Brev från Aberas nya storägare
Abera Bioscience inleder nya studier inom pandemisk influensa - CEPI godkänner förlängning av projekt
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools